228670 — Ray Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Ray Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	55,205	90,336	128,998	145,882	79,843
Cost of Revenue
Gross Profit	26,602	31,985	62,540	70,997	36,000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	50,624	89,257	112,792	144,046	128,200
Operating Profit	4,581	1,079	16,206	1,835	-48,358
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	8,865	-2,764	11,466	-4,234	-56,227
Provision for Income Taxes
Net Income After Taxes	7,904	57.2	7,957	-3,048	-63,327
Minority Interest
Net Income Before Extraordinary Items
Net Income	7,904	-12.8	7,957	-2,146	-60,427
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	7,904	-12.8	7,957	-2,146	-60,427
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	594	93.8	530	42.1	-3,692
Dividends per Share